Для корректного отображения сайта воспользуйтесь другим бразуером
28 October 2026
A Joint Working Meeting of the FIC Working Group on Healthcare and Pharmaceutical Industry Development of the Foreign Investors’ Council under the President of the Republic of Kazakhstan Was Held

On 28 October 2026, a working meeting of the FIC Working Group on Healthcare and Pharmaceutical Industry Development of the Foreign Investors’ Council under the President of the Republic of Kazakhstan was held.

The Kazakhstani side was represented by Meiramgul Akimbekovna Ibraimova, Chief Expert of the Division for Technical Regulations on Food Products of the Committee for Sanitary and Epidemiological Control of the Ministry of Healthcare of the Republic of Kazakhstan.

The foreign side was represented by:

·        Elmira Pistayeva — Senior Government Relations Adviser, Kazakhstan Foreign Investors’ Council Association;

·        Yaroslava Budach — Director of Research and Development, Polpharma Group;

·        Askhat Mubarakov — Market Access Manager, Khimpharm JSC (SANTO, a member of the Polpharma Group).

The meeting focused on improving the regulation of dietary supplements in Kazakhstan, ensuring their safety and strengthening pharmacovigilance, as well as addressing current issues related to product registration and amendments to regulatory requirements. The parties also considered the possibility of holding a roundtable with experts from the European Union to exchange international experience in this area.

The parties emphasised the importance of continued constructive dialogue between government authorities and foreign businesses and expressed their commitment to further cooperation and the promotion of responsible pharmacological practices in accordance with the legislation of the Republic of Kazakhstan.

 

Share: